Sponsor Innovation Webinar: Biomarker-Enhanced Clinical Assessment of Sepsis and Acute Kidney Injury
This session will overview clinical assessment of acute kidney injury using biomarkers.
All healthcare providers
At the end of the session, attendees should be able to:
- Understand the role of renal biomarkers in assessment of AKI with clinical judgement;
- Understand the role of procalcitonin in tracking, assessing and delineating sepsis;
- Understand the interplay in intensive care of multiple biomarkers in assessing care.
Louis M. Guzzi, MD, FCCM
Director, Critical Care Medicine, Florida Hospital Orlando
Dr. Guzzi is quadruple board-certified in critical care medicine, anesthesiology, internal medicine and neocritical care. He cares for patients at Florida Hospital Orlando and has more than 20 years of experience to his name. Dr. Guzzi is a graduate of the Georgetown University School of Medicine in Washington, D.C. and carried out his residency training at Dwight D. Eisenhower Army Medical Center and Walter Reed Army Medical Center, remaining at Walter Reed for his advanced fellowship training in critical care medicine. He actively practices both anesthesiology and critical care medicine and lectures both nationally and internationally on both topics.
No continuing education credits are offered for this sponsored webinar.
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.